Creekmur Asset Management LLC Gain Therapeutics, Inc. Transaction History
Creekmur Asset Management LLC
- $292 Billion
- Q1 2024
A detailed history of Creekmur Asset Management LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Creekmur Asset Management LLC holds 4,440 shares of GANX stock, worth $5,328. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,440
Previous 4,440
-0.0%
Holding current value
$5,328
Previous $14.5 Million
15.47%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
33Shares Held
2.58MCall Options Held
22.2KPut Options Held
16K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$706,0920.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$679,3560.1% of portfolio
-
Raymond James & Associates St Petersburg, FL260KShares$312,0220.0% of portfolio
-
Royal Bank Of Canada Toronto, A6249KShares$298,2000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA177KShares$212,5090.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $14.3M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...